financetom
Business
financetom
/
Business
/
Apogee Enterprises Insider Sold Shares Worth $732,720, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apogee Enterprises Insider Sold Shares Worth $732,720, According to a Recent SEC Filing
Apr 25, 2024 1:55 PM

04:36 PM EDT, 04/25/2024 (MT Newswires) -- Troy R Johnson, President, Architectural Services, on April 23, 2024, sold 12,000 shares in Apogee Enterprises ( APOG ) for $732,720. Following the Form 4 filing with the SEC, Johnson has control over a total of 33,433 shares of the company, with 33,433 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/6845/000000684524000077/xslF345X03/wk-form4_1714075220.xml

Price: 60.02, Change: -1.30, Percent Change: -2.12

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tinder CEO Iosotaluno to step down in July
Tinder CEO Iosotaluno to step down in July
May 26, 2025
(Reuters) -Tinder CEO Faye Iosotaluno said on Thursday that she would step down in July, as the dating app aims to attract more users. Iosotaluno, who has led Tinder since January 2024, oversaw the dating platform's increased focus on personalization through deeper integration of artificial intelligence into its recommendation system. Tinder parent Match Group's ( MTCH ) CEO, Spencer Rascoff,...
GSK's asthma drug wins FDA approval to treat 'smoker's lung'
GSK's asthma drug wins FDA approval to treat 'smoker's lung'
May 26, 2025
May 22 (Reuters) - The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic lung disease commonly known as smoker's lung, the company said on Thursday. The approval expands the use of the drug, Nucala, as an add-on treatment for patients with a type of chronic obstructive pulmonary disease. Sanofi...
Arcutis Biotherapeutics' Foam Psoriasis Treatment Gets FDA Approval
Arcutis Biotherapeutics' Foam Psoriasis Treatment Gets FDA Approval
May 26, 2025
02:52 PM EDT, 05/22/2025 (MT Newswires) -- Arcutis Biotherapeutics ( ARQT ) said Thursday that the US Food and Drug Administration approved the foam version of Zoryve for treating plaque psoriasis on the scalp and body in patients aged 12 and older. Zoryve foam is a steroid-free, once-daily topical treatment that is now available across the US, the company said....
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved